CN103405421B - Application of Chukrasone B in medicine for treating cervical cancer - Google Patents
Application of Chukrasone B in medicine for treating cervical cancer Download PDFInfo
- Publication number
- CN103405421B CN103405421B CN201310386099.9A CN201310386099A CN103405421B CN 103405421 B CN103405421 B CN 103405421B CN 201310386099 A CN201310386099 A CN 201310386099A CN 103405421 B CN103405421 B CN 103405421B
- Authority
- CN
- China
- Prior art keywords
- chukrasone
- cervical cancer
- application
- medicine
- human cervical
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 229930187319 chukrasone Natural products 0.000 title claims abstract description 25
- 206010008342 Cervix carcinoma Diseases 0.000 title claims abstract description 18
- 208000006105 Uterine Cervical Neoplasms Diseases 0.000 title claims abstract description 18
- 201000010881 cervical cancer Diseases 0.000 title claims abstract description 18
- 239000003814 drug Substances 0.000 title claims abstract description 17
- 238000002360 preparation method Methods 0.000 claims abstract description 12
- LVTJOONKWUXEFR-FZRMHRINSA-N protoneodioscin Natural products O(C[C@@H](CC[C@]1(O)[C@H](C)[C@@H]2[C@]3(C)[C@H]([C@H]4[C@@H]([C@]5(C)C(=CC4)C[C@@H](O[C@@H]4[C@H](O[C@H]6[C@@H](O)[C@@H](O)[C@@H](O)[C@H](C)O6)[C@@H](O)[C@H](O[C@H]6[C@@H](O)[C@@H](O)[C@@H](O)[C@H](C)O6)[C@H](CO)O4)CC5)CC3)C[C@@H]2O1)C)[C@H]1[C@H](O)[C@H](O)[C@H](O)[C@@H](CO)O1 LVTJOONKWUXEFR-FZRMHRINSA-N 0.000 claims description 7
- 230000000694 effects Effects 0.000 abstract description 8
- 230000012010 growth Effects 0.000 abstract description 7
- 101000963221 Homo sapiens mRNA guanylyltransferase Proteins 0.000 abstract description 6
- 102100039604 mRNA guanylyltransferase Human genes 0.000 abstract description 6
- 229940079593 drug Drugs 0.000 abstract description 5
- 238000011161 development Methods 0.000 abstract description 2
- 238000011156 evaluation Methods 0.000 abstract description 2
- 230000005764 inhibitory process Effects 0.000 abstract 2
- 208000001894 Nasopharyngeal Neoplasms Diseases 0.000 abstract 1
- 230000000259 anti-tumor effect Effects 0.000 abstract 1
- 238000000338 in vitro Methods 0.000 abstract 1
- 208000025848 malignant tumor of nasopharynx Diseases 0.000 abstract 1
- 201000011216 nasopharynx carcinoma Diseases 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 description 9
- 208000019065 cervical carcinoma Diseases 0.000 description 6
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 3
- 239000002246 antineoplastic agent Substances 0.000 description 3
- 229940041181 antineoplastic drug Drugs 0.000 description 3
- 239000001963 growth medium Substances 0.000 description 3
- 230000002401 inhibitory effect Effects 0.000 description 3
- 241001156380 Chukrasia tabularis Species 0.000 description 2
- 102000006628 Kv1.2 Potassium Channel Human genes 0.000 description 2
- 108010087141 Kv1.2 Potassium Channel Proteins 0.000 description 2
- 206010028980 Neoplasm Diseases 0.000 description 2
- 239000002671 adjuvant Substances 0.000 description 2
- 201000011510 cancer Diseases 0.000 description 2
- 239000002775 capsule Substances 0.000 description 2
- 230000031700 light absorption Effects 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- 229930014626 natural product Natural products 0.000 description 2
- 230000004083 survival effect Effects 0.000 description 2
- 241001597008 Nomeidae Species 0.000 description 1
- 229930012538 Paclitaxel Natural products 0.000 description 1
- 102000004257 Potassium Channel Human genes 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 230000001464 adherent effect Effects 0.000 description 1
- 230000001093 anti-cancer Effects 0.000 description 1
- 230000000118 anti-neoplastic effect Effects 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- 238000004113 cell culture Methods 0.000 description 1
- 230000010261 cell growth Effects 0.000 description 1
- 239000012531 culture fluid Substances 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 231100000206 health hazard Toxicity 0.000 description 1
- 150000002611 lead compounds Chemical class 0.000 description 1
- 238000011275 oncology therapy Methods 0.000 description 1
- 229960001592 paclitaxel Drugs 0.000 description 1
- 230000003285 pharmacodynamic effect Effects 0.000 description 1
- 108020001213 potassium channel Proteins 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 238000012827 research and development Methods 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- RCINICONZNJXQF-MZXODVADSA-N taxol Chemical compound O([C@@H]1[C@@]2(C[C@@H](C(C)=C(C2(C)C)[C@H](C([C@]2(C)[C@@H](O)C[C@H]3OC[C@]3([C@H]21)OC(C)=O)=O)OC(=O)C)OC(=O)[C@H](O)[C@@H](NC(=O)C=1C=CC=CC=1)C=1C=CC=CC=1)O)C(=O)C1=CC=CC=C1 RCINICONZNJXQF-MZXODVADSA-N 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Abstract
Description
Claims (1)
- The application of 1.Chukrasone B in preparation treatment cervical cancer medicine, described Compound C hukrasone B structure as formula Ishown in:formula I.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201310386099.9A CN103405421B (en) | 2013-08-29 | 2013-08-29 | Application of Chukrasone B in medicine for treating cervical cancer |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201310386099.9A CN103405421B (en) | 2013-08-29 | 2013-08-29 | Application of Chukrasone B in medicine for treating cervical cancer |
Publications (2)
Publication Number | Publication Date |
---|---|
CN103405421A CN103405421A (en) | 2013-11-27 |
CN103405421B true CN103405421B (en) | 2015-04-29 |
Family
ID=49598496
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201310386099.9A Expired - Fee Related CN103405421B (en) | 2013-08-29 | 2013-08-29 | Application of Chukrasone B in medicine for treating cervical cancer |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN103405421B (en) |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1759833A (en) * | 2005-09-30 | 2006-04-19 | 青岛大学 | Application of indole-2,3-diketone in preparing medication for antivirus or immunopotenfiator |
-
2013
- 2013-08-29 CN CN201310386099.9A patent/CN103405421B/en not_active Expired - Fee Related
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1759833A (en) * | 2005-09-30 | 2006-04-19 | 青岛大学 | Application of indole-2,3-diketone in preparing medication for antivirus or immunopotenfiator |
Also Published As
Publication number | Publication date |
---|---|
CN103405421A (en) | 2013-11-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN105250250A (en) | Application of Nootkatone in preparation of medicine for treating nasopharyngeal carcinoma | |
CN103405421B (en) | Application of Chukrasone B in medicine for treating cervical cancer | |
CN103405447B (en) | The application of Chukrasone A in preparation treatment medicine for nasopharyngeal | |
CN103405420B (en) | The application of Chukrasone B in preparation treatment medicine for nasopharyngeal | |
CN105267193A (en) | Application of Periconianone B to preparation of medicine for treating ovarian cancer | |
CN105267221A (en) | Application of Norzoanthamine in preparation of drugs for treating prostate cancer | |
CN103405455B (en) | The application of Chukrasone A in preparation treatment laryngeal carcinoma medicine | |
CN103405451B (en) | The application of Chukrasone A in preparation treatment tongue cancer drug | |
CN103446092B (en) | The application of Incarviatone A in preparation treatment cervical cancer medicine | |
CN103479632B (en) | The application of Lycojaponicumin B in preparation treatment cervical cancer medicine | |
CN103446147B (en) | The application of Lycojaponicumin C in preparation treatment cervical cancer medicine | |
CN103463052B (en) | The application of Lycojaponicumin A in preparation treatment cervical cancer medicine | |
CN103446086B (en) | The application of Incarviatone A in preparation treatment gastric cancer medicament | |
CN103405416B (en) | The application of Chukrasone B in preparation treatment endometrial cancer drug | |
CN103520175B (en) | The application of a kind of compound in preparation treatment cervical cancer medicine | |
CN103463050B (en) | Application of Lycojaponicumin A in preparation of gastric cancer treatment drug | |
CN103446089B (en) | The application of Incarviatone A in preparation treatment medicine for nasopharyngeal | |
CN103446143B (en) | The application of Lycojaponicumin C in preparation treatment gastric cancer medicament | |
CN103446091B (en) | The application of Incarviatone A in preparation treatment laryngeal carcinoma medicine | |
CN103463059B (en) | The application of Lycojaponicumin B in preparation treatment laryngeal carcinoma medicine | |
CN103405444B (en) | The application of Chukrasone A in preparation treatment bladder cancer medicine | |
CN103463033B (en) | The application of Lycojaponicumin B in preparation treatment gastric cancer medicament | |
CN103405453B (en) | The application of Chukrasone A in preparation treatment pancreatic cancer drug | |
CN103462969B (en) | The application of Incarviatone A in preparation treatment breast cancer medicines | |
CN103463069B (en) | The application of Lycojaponicumin C in preparation treatment medicine for nasopharyngeal |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C53 | Correction of patent of invention or patent application | ||
CB03 | Change of inventor or designer information |
Inventor after: Wu Junhua Inventor after: Cao Yin Inventor after: Wang Hui Inventor after: Wang Zezheng Inventor after: Wu Junyi Inventor after: Zhang Guang Inventor after: Jiang Chunping Inventor before: Wang Hui Inventor before: Wang Zezheng Inventor before: Wu Junyi Inventor before: Zhang Guang Inventor before: Jiang Chunping Inventor before: Wu Junhua |
|
COR | Change of bibliographic data |
Free format text: CORRECT: INVENTOR; FROM: WANG HUI WANG ZEZHENG WU JUNYI ZHANG GUANG JIANG CHUNPING WU JUNHUA TO: WU JUNHUA CAO YIN WANG HUI WANG ZEZHENG WU JUNYI ZHANG GUANG JIANG CHUNPING |
|
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20150429 Termination date: 20160829 |
|
CF01 | Termination of patent right due to non-payment of annual fee |